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Abstract
Cancer and related lifestyle diseases are on the increase across Asia and already account for over half the
disease-associated mortality in the vast majority of the included countries. An understanding of  the epidemiology
is therefore of paramount importance. In addition, given the immensity of the problem, cooperation among all
the interested parties is of the essence. The present series of reviews were complied with the aim of promoting
better comprehension and interaction, focusing on cancer prevalence and the underlying risk and preventive
factors in Asia. Data from Cancer Incidence in Five Continents and Globocan 2002, published by the International
Agency for Research on Cancer, as well as various other cancer registry sources,  were thus married with research
information in the public domain, accessible through PubMed.   It is hoped that the comprehensive approach
adopted for the different regions will help bring together all of the Asian community of individuals involved in
cancer epidemiology and control and contribute to establishment of Asian networks for collaborative research.
The major players and the overall picture for cancer control are covered in the present overview.  Further
details are then provided in seven separate regional reviews: for North-Western and Central  Asia; South-West
Asia; South Asia; Mainland South-East Asia; Peninsular and Island South-East Asia, the Pacific; and North-
East Asia. The final section covers possible organ-based strategies for cancer control and, lastly, an Appendix
has been included listing research institutes and staff in Asia to facilitate contacts between interested individuals.
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Introduction - Players in Asia
Asia has a population of over four billion and accounts
for over one half of the cancer burden of the world.
Commensurate with its geographical extent, there are a
number of organizations involved in cancer control within
its frontiers, including four regional offices of the World
Health Organization (see Figure 1). Other interested
parties are the International Agency for Research on
Cancer (IARC) and the International Association of
Cancer Registries IACR), both based in Lyon, France,
the Asian Pacific Federation of Organizations for Cancer
Control (APFOCC), the International Union Against
Cancer Asian Regional Office for Cancer Control (UICC-
ARO) and the Asian Pacific Organization for Cancer
Prevention (APOCP). The possibility of an Asian Network
of Cancer Registries is also now being mooted (ANCR),
which might also join the APOCP and UICC-ARO in
having the APJCP as its official publication.
WHO Regional Offices
There is involvement of four of the total of six WHO
regional offices:  Europe (for Turkey, Israel, Siberia and
Central Asia), the Eastern Mediterannean (for the Arab
countries, Iran, Pakistan and Afghanistan), the South-East
(India, Sri Lanka, Nepal, Bhutan, Bangladesh, North
Korea, Myanmar, Thailand and Indonesia) and the Western
Pacific (Mongolia, China, South Korea, Japan, Viet Nam,
Laos and Cambodia, Malaysia, the Philippines, Papua
New Guinea and the Pacific Islands).
All ostensibly have personnel responsible for
promoting control of cancer within their Non-
Figure 1. Parties Active in Cancer Control in Asia and
the Pacific
1UICC Asian Regional Office for Cancer Control, apocpcontrol@yahoo.com, 2Cancer Information Services and Surveillance Division,
Cancer Control and Information Services, National Cancer Center, Tokyo, Japan, 3APOCP Secretary-General, Department of
Preventive Medicine, College of Medicine, Seoul National University, Seoul, Korea, 4APOCP President, Cancer Control Department,
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Communicable Disease sections. In addition to publication
of education materials, the Regional Offices are meant to
play essential roles in assisting establishment of so-called
‘Collaborating Centres’. By definition, a WHO
collaborating center should form part of an inter-
institutional collaborative network set up by WHO in
support of its programme at the country, intercountry,
regional, interregional or global level, as appropriate. Each
centre must also participate in the strengthening of country
resources, in terms of information, services, research and
training. Collaborating Centres with direct relevance to
cancer control are unfortunately very few in relation to
population size and the burden of cancer in Asia (see Table
1). Furthermore, none of them have accessible websites
from which an assessment of functions could be made.
This is an absolutely abysmal situation.
International Agency for Research on Cancer (IARC)
While the IARC (www.iarc.fr), a WHO agency with
a separate funding mechanism, does not have an office in
Asia, its research groups are active in collaboration with
scientists in many of the included countries. A number of
training courses have been held in Asia and the Pacific
(see Table 2), in addition to the summer courses which
are staged every year in Lyon itself.  Of particular interest,
the Descriptive Epidemiology Production Group in the
IARC (http://www.iarc.fr) houses the secretariat for the
International Association of Cancer Registries and is
responsible for the Agencies contribution to world-wide
cancer registration. It has now been joined by a Data
Analysis and Interpretation group. These are involved in
producing the Cancer Incidence in Five Continents (CIV)
series, volumes IV-IX of which (Waterhouse et al., 1982;
Table 3. Numbers of Asian and Pacific Registries
Included in the Series of Nine Volumes of CIV
Volume I     II III     IV    V     VI     VII   VIII     IX
Countries 4 4 5 6 8 10 12 15 18
Registries 4 5 7 11 17 23 26 43 48
Hawaii, USA 1 1 1 1 1 1 1 1 1
Israel* 1 1 1 1 1 1 1 1 1
Singapore* 1 1 1 1 1 1 1 1
Japan 1 2 3 4 4 6 6 6 7
India 1 1 2 5 4 6 9 7
China 2 3 4 4 10 6
  Taiwan* 1
Kuwait* 1 1 1 1 1
Philippines 1 2 1 2 1
Kyrgyzstan 1
Thailand 2 2 3 3
French Polynesia 1 1 1
Korea* 1 4 9








Table 2. IARC Courses in Asia and the Pacific
(www.iarc.fr/Education-Training/Training-Courses/
International-Courses)
IARC-NCC International Course on Introduction to Cancer
Registration and its Application  Sept 2008, Seoul, Korea
IARC International Course on Molecular Cancer Epidemiology
Sept 2006, Seoul, Korea
IARC International Course on Cancer Epidemiology Principles
and Methods May 2004, Tonga, Pacific
IARC-NUS Course on Molecular Epidemiology
Sept 2003, Singapore
IARC International Course on Cancer Epidemiology Principles
and Methods Sept 2003, Trivandrum, India
Muir et al., 1987;  Parkin et al., 1992; 1997; 2002; Curado
et al., 2007) were utilized for the present series of reviews
as well as the Globocan 2002 estimates of incidence and
mortality burden (Ferlay et al., 2004). The numbers of
registries from different countries of the region included
in CIV are summarized in Table 3. All of the countries of
the world are covered in the Globocan 2002 estimates.
Globocan 2007 is now on the way.
The Agency has been very active at helping set up
regional registries in Asia. It has also published a number
of other scientific publications covering various aspects
of cancer registration, although the last was issued in 2003.
Although IARC Press no longer exists, various
publications like ‘Cancer Registration: Principles and
Methods’ are now available as pdf files, freely
downloadable from www.iarc.fr.
International Association for Cancer Registries (IACR)
We are dependent on our cancer registries for accurate
information on incidences and mortality rates, as well as
Table 1. WHO Collaborating Centres for Cancer
Control in Asia and the Pacific (www.who.int/whocc/)
SEARO (1/92)*
Cancer Prevention, Screening and Detection
Tata Memorial Hospital, Mumbai, shastri@tmcmail.org
www.tatamemorial.centre.com
WPRO (3/197)
Primary Prevention, Diagnosis/Treatment of Gastric Cancer
National Cancer Center, Tokyo, Japan
No website,  tksano@ncc.go.jp
Research on Cancer
Cancer Hospital and Institute,Chinese Academy of
Medical Sciences, Beijing, China
No website, caodx@sun.ihep.ac.cn
Research on Cancer
Cancer Centre, Sun Yat-sen University, Guangzhou
No website, wyzz@gzsms.edu.cn
Cancer Registration, Prevention and Early Detection,
National Cancer Center, Seoul, Korea
www.ncc.re.kr (but no information), yec0703@ncc.re.kr
EMRO (2/66)
Cancer Control and Lymphoma Research
Kuwait Cancer Control Center, M of H, Kuwait
No website,  Elbasmy@yahoo.com
Cancer Prevention and Control
King Faisal Specialist Hospital and Research Center
No website, no email address
ERO (0/344 in Asia, 4/344 in Europe itself)
* number with cancer in their title/total number of CCs
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Figure 2. Cancer Registries in the Various Countries of Asia and the Pacific, Subdivided into Categories
trends over time. These are essential data for evidence-
based cancer control programs. Due in large part to the
efforts of the International Association for Cancer
Registries (IACR)  (http://www.iacr.com.fr), founded in
1966 as a professional society dedicated to fostering the
aims and activities of cancer registries worldwide, and
the support of IARC, with long-term dedication by Max
Parkin, there are many cancer registries in Asia already
producing data, although the indices of quality are very
variable. The major division is into hospital- and
population-based, but the former may also vary from
simple Pathology Department surveys to coordinated
efforts to registration of all cases diagnosed in an
institution.
An overview of the majority of registries already active
in Asia, to our knowledge, is given in Figure 1, with
division into  whether Voting or non-Voting members of
the IACR (decided on the level of activity achieved by
the registry), the former being further divided into those
deemed to have or lack sufficient accuracy for inclusion
in CIV. In the last issue, stricter application of criteria
than was previously the case resulted in a number of cancer
registries no longer being included in CIV, despite an
increase overall over the numbers in previous volumes
(see Table 3). The registries were in fact graded into
different acceptable grades (along with a grade not
included) on the basis of percentages of microscopically
verified and death only certified (see Shin et al., 2009),
many of the Asian  registries being included in low
categories.
At the 22nd Annual Scientific Meeting of the
International Association of Cancer Registries, held in
Khon Kaen, Thailand, a poster session was dedicated to a
review of the current situation with respect to cancer
registration on the Asian continent.  All of the contributors
were asked to prepare an “extended abstract” which would
include a rather structured account of cancer registration
activities in the country, subsequently published as an
APJCP Supplement (Parkin and Vatanasapt, 2001).  The
included countries/registries were Jordan (Qasem, 2001),
Oman (al-Lawati et al., 2001), Saudi Arabia (Al Hamdan
et al., 2001), Iran (Mosavi-Jarrahi et al., 2001), Pakistan
(Bhurgri, 2001), India (Gajalakshmi et al., 2001), Thailand
(Deerasamee et al., 2001), Viet Nam (Anh, 2001),
Malaysia (Rosemawati and Sallehudin, 2001), the
Philippines (Esteban et al., 2001), China (Wang, 2001),
Hong Kong (Foo et al., 2001), Taiwan (You et al., 2001),
Mongolia (Munkhtaivan et al., 2001), Korea (Ahn, 2001)
and Japan (Oshima et al., 2001).
Asian Pacific Organization for Cancer Prevention
(APOCP)
The APOCP was set up in 1999 as a professional body
f scientists to promote all aspects of cancer prevention
across the Asian Pacific. Its main activities have been to
publish the Asian Pacific Journal of Cancer Prevention,
now in its 11th year and cited on both PubMed and Science
Citation Index Expanded, with papers freely downloadable
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as pdf files from the APOCP website (www.apocp.org),
and hold scientific meetings. At two year intervals a
General Assembly Conference (GAC) has been held, the
first in Nagoya in 2002, the second in Seoul in 2004, the
third in Bangkok in 2006 and the fourth in Beijing in 2008.
The fifth APOCP-GAC, with the theme ‘Bridging
Continents for Cancer Control’ is scheduled in Istanbul,
in April 2010, with Murat Tuncer as the President. In
addition, Regional Conferences have been held in Izmir,
Khon Kaen, Rasht and Nagoya, along with a number of
smaller specialist meetings at irregular intervals across
Asia.
International Union Against Cancer/Union Internationale
Contra Cancrum (UICC) Asian Regional Office
In addition to the UICC Head Office in Geneva, with
a total of 90 members in Asia (see the Appendix), and  so-
called ‘spoke’ in India, already responsible for producing
a Handbook on Cancer Control in the sub-continent, and
another in China, there is presently a UICC Asian Regional
Office for Cancer Control (UICC-ARO), financed
primarily by the Japanese National Committee of the
UICC. Set up in 2006, this is now responsible for
production of the APJCP as an electronic journal,  in
coordination with the APOCP. It also is involved in
organizing symposia and a number of research projects
and helping establish consortia for collaboration across
Asia. Two are already in existence, for prostate cancer
(Cheng et al., 2006) and for breast cancer (Yip et al., 2009).
Its Head is also responsible for a program of Scientific
English Training in different venues across Asia.
Asian Pacific Federation of Organizations for Cancer
Control (APFOCC)
In 1973, scientists from many countries in Asia
assembled with representatives  of the WHO, UICC and
IARC to establish  the Asian Federation of Organizations
for Cancer Control (AFOCC).  The name was changed to
the Asia-Pacific Federation  (APFOCC) in 1979, because
members  were also accepted from  Oceania. The total is
now 21 (see the Appendix), the majority being National
Oncology/Cancer Societies or National Cancer Centres/
Institutes. Since the first meeting, the Asian Pacific Cancer
Congress has been held every two years.  At the last, in
November 2009 in Tsukuba, Japan, with the theme
‘Cancer Control - Setting the Focus on Unique Asian
Pacific Contributions’ (www2.convention.jp/2-th-apcc/),
in collaboration with the UICC-ARO  consortia were
established for each of the major organ sites to allow more
comprehensive coordinated activities in the future.
Asian & Pacific Islander American Health Forum
(APIAHF)/Secretariat of the Pacific Community (SPC)
The mission of the APIAHF (www.apiahf.org) is to
enable Asian Americans and Pacific Islanders, in the USA
and elsewhere, to attain the best possible level of health
and well-being, primarily through community-based
efforts. The base is in San Francisco and the majority of
projects have been set up to target populations on the
mainland.
The SPC (www.spc.int) has a health lifestyle section
which is focusing attention on non-communicable disease
control.
Regional and National Players within Asia
In many of the countries within Asia there are national
cientific organizations responsible for holding meetings
and in some cases publishing journals or newsletters
within various cancer fields (see Table 5). There are also
a number of research collaborative groups like the Japan
Collaborative Cohort Study for Evaluation of Cancer
(Tamakoshi, 2007), the Research Group for the
Development, Evaluation of Cancer Prevention Strategies
in Japan and the Japan Public Health Center-based
prospective study group, and the Korean Multi-center
Cancer Cohort Study including a Biological Materials
Bank (KMCC-I) and other genomic cohorts in Korea (Yoo
et al., 2002; 2005). The Hospital-based Epidemiologic
Research Program at Aichi Cancer Center (HERPACC),
Japan (Tajima et al., 2000) also deserves mention in this
context. Furthermore, there are two collaborative studies
funded by Japan within North-East  and South East Asia,
entitled KOJACH (Korea, Japan and China) and the
I ternational Collaborative Epidemiologic Study of Host
and Environmental Factors for Gastrointestinal Tract
Cancers in Southeast Asian Countries.
The present supplement was conceived with the idea
of bringing together interested parties within Asia in line
with recent moves to form an Asian Cancer Registry
Network (Moore et al., 2008). Taking advantage of the
facilities which are already available in the form of cancer
registries (see Figure 2), it is to be hoped that collaboration
can  be achieved with all the necessary players involved
(Moore et al., 2009).
Cancer Control Programs in Asia
Data available from WHO and other websites on
country flags and population sizes in 1995 and predicted
for 2025, as well as burden of chronic disease in Asia and
the Pacific are summarized in Table 5. The cancer
Table 5. National/Supranational Organizations in Asia
Asian Pacific Organisation for Cancer Prevention
Asian Pacific Journal of Cancer Prevention
Middle East Cancer Consortium  (http://mecc.cancer.gov/)
Gulf Center for Cancer Registration (http://www.gccr.org)
Iranian Group for Cancer Registration
Indian Group for Cancer Registration
Thai Association for Cancer Epidemiology
Chinese Association for Cancer Research
Korean Society for Cancer Prevention
Korean Journal of Cancer Prevention
Japanese Association of Cancer  Research
Cancer Science
Japanese Association  for Cancer Detection and Diagnosis
Japanese Assocation for Cancer Prevention
Newsletter
Japanese Society of Cancer Epidemiology
Newsletter
Japanese Society of Cancer Molecular Epidemiology
Japanese Society of Cancer Registries
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Table 6.  Population and Disease Profiles for Countries in the Asian Pacific Region
Country        Flag Population         Cancer*     Diabetes+       Circulatory#
    (x106)     Male Female       (% Inc)     Ischem  Cerebro
         1995   2025    Inc    Mort      %#        Inc      Mort   (%)#   1995 2025     M   F     M    F
North West and Central
Turkey 61.9 90.9 137.3 107.8 N 91.2 58.6 N 4.2   7.8 N N N N
Armenia 3.6   4.7 212.9 155.3 18 171.2 94.5 16 3.6   4.7 33 34 14 21
Georgia  5.5   6.1 171.4 115.9 11 161.4 86.7 10 4.3   5.2 38 41 22 26
Azerbaijan  7.6 10.1 178.1 132.7 13 139.4 80.2 12 4.2   7.8 37 39 9 13
Iran 68.0 83.2  116.8 89.6 N 93.1 64.3 N 3.3 7.7 N N N N
Turkmenistan 4.1 6.7 152.0 110.6 7 128.0 76.6 7 1.7   3.7 23 26 3 5
Uzbekistan 22.8 37.7 114.7 79.4 7 106.6 58.8 7 1.6   3.4 27 34 10 15
Kazakhstan 17.1 21.7  295.3 221.2 12 205.1 120.1 13 3.0   4.5 24 29 10 18
Kyrgyzstan 4.7 7.1 167.2 122.3 8 145.0 81.3 9 1.9   3.5 22 27 15 19
Tadjikistan 6.1 11.8 98.6 71.0 N 97.1 56.8 N 1.4   2.8 N N N N
Afghanistan 20.8 50.3 115.0 86.6 N 114.9 73.3 N 2.2 2.9 N N N N
South-West Asia
Syria 14.6 33.5  179.7 132.4 N 167.4 104.1 N 3.4   8.7 N N N N
Lebanon  3.0   4.4  179.7 135.1 N 167.4 104.1 N 3.8   8.0 N N N N
Israel   5.6   7.8 295.6 132.6 23 303.3 142.6 23 4.1   6.6 16 15 5 7
Jordan  5.4   9.0  117.9 84.3 N 112.1 67.8 N 3.4   7.8 N N N N
Egypt 62.9 97.3  101.0 87.0 5 84.0 64.9 4 3.4   6.5 3 2 6 6
Saudi Arabia 17.9 42.7 123.4 92.5 N 118.1 74.2  N 3.4   7.1 N N N N
Yemen 14.5 33.7 123.4 92.5 N 118.1 73.2 N 1.6   3.2 N N N N
Oman   2.2   6.1 94.2 71.2 N 77.9 50.2 N 3.8   6.5 N N N N
UAE  1.9   3.0 123.4 91.9 N 118.1 73.9 N 13.7 20.9 N N N N
Qatar   0.8   1.2 149.8 111.4 9 151.9 98.1 15 4.4   6.9 20 12 7 11
Bahrain 0.6   0.9 147.8 113.8 12 141.1 89.3 12 5.4 11.4 9 6 2 3
Kuwait 1.6   2.8 101.8 79.5 10 115.0 72.0 16 4.5   7.6 20 9 5 4
Iraq 20.4 42.7 123.4 90.2 N 118.1 74.7 N 2.6   5.0 N N N N
South Asia
Pakistan 140.5 284.8 129.6 94.4 N 154.5 91.9 N  3.2   6.1 N N N N
India 935.8 1,392 99.0 73.4 N 104.4 67.6 N  2.9   5.8 N N N N
Sri Lanka 18.3 25.0 99.0 69.6 5 104.4 63.2 7  3.2   6.8 5 4 3 3
Bangladesh 120.4 196.1 99.0 73.3 N 104.4 63.0 N 2.2 5.4 N N N N
Nepal 21.9 40.7 105.3 78.3 N 110 67.3 N 1.6   3.3 N N N N
Bhutan 1.6 3.1 105.3 78.3 N 110 67.3 N 1.6   3.3 N N N N
* Incidence and mortality data from Globocan 2002, Ferlay et al., 2004; +www.who.int/diabetes/facts/; #Percentage of total deaths
due to the disease, www.who.int/whosis/database/mort/WHO Mortality,  Armenia/Azerbaijan/Kazakhstan/Kuw it/Kyrgyzstan,
2005, Bahrain/Georgia/Turkmenistan, 2001, Egypt/Uzbekistan, 2000, Israel, 1999, Qatar/Sri Lanka, 1995
incidence and mortality data are  overall estimates  from
Globocan 2002, and the percentage values are for mortality
from all neoplasms as a proportion of the total deaths.
These latter are very incomplete, only being available for
20 of the 50 countries listed, 64% for the North-West,
38% for the South-West, 17% for the South, 30% for the
South-East, 17% for the Pacific and 75% for the North-
East. In addition, in only a very small proportion of cases
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Table 6 continued.  Population and Disease Profiles for Countries in the Asian Pacific Region
Country     National  Population         Cancer      Diabetes    Circulatory
      Flag       (106)     Male Female          (%)            Disease (%)
1995    2025    Inc     Mort    (%)         Inc      Mort   (%)   1995 2025 Cerebro   Cardio
Mainland South-east Asia
Myanmar 41.7 53.0 139.0 109.0 N 117.8 77.3 N 1.3 2.5 N N N N
Thailand 58.8 73.6 148.2 119.7 12 123.7 79.3 12 2.6 3.7 2 2 4 4
Laos 4.8 9.7 108.9 87.6 N 96.9 63.0 N 1.0 1.3 N N N N
Cambodia 10.3 19.7 144.3 110.5 N 115.5 71.1 N 1.1 1.6 N N N N
Viet Nam 74.5 118.1 143.5 116.2 N 103.6 67.1 N 1.1 2.0 N N N N
Peninsular and Island South-East Asia
Malaysia 20.1 31.6 152.1 118.2 N 140.4 88.7 N 4.7 7.8 N N N N
Singapore 3.5 5.1 225.0 161.3 29 196.4 108.7 28 9.4 13.6 21 16 7 11
Brunei 0.3 0.5 145.7 112.7 N 128.6 83.0 N 6.0 9.8 N N N N
Indonesia 197.6 275.6 97.2 55.3 N 106.8 63.3 N 4.3 7.7 N N N N
Philippines 67.6 104.5 190.8 150.9 8 181.7 123.7 10 4.1 7.5 9 8 5 6
Pacific Islands
Papua NG 4.3 8.0 147.9 104.6 N 165.4 103.1 N 3.6 4.9 N N N N
Solomons 0.4 0.8 181.2 132 N 201.6 125.6 N 3.3 5.1 N N N N
Vanuatu 0.2 0.3 181.2 132 N 201.6 125.6 N 3.0 5.6 N N N N
Fiji 0.8 1.2 87 65.3 3 135.7 83.9 11 4.6 6.0 18 5 13 14
Guam 0.2 0.2 151.3 114.5 N 143.8 88.6 N N N N N N N
Samoa 0.2 0.3 169.3 126.3 N 159.3 97.6 N 2.0 2.3 N N N N
North-east Asia
Mongolia 2.4 3.8 238.6 203.7 17 174.0 86.2 17  1.3   2.5 8 8 6 7
China 1,221 1,526 204.9 159.8 N 129.5 86.7 N 1.6   2.9 N N N N
N Korea 23.9 33.4 285.7 179.6 31 155.3 73.9 22 3.8 6.7 7 7 11 16
S Korea 45.0 54.4 285.7 179.6 31 155.3 73.9 22 3.8   6.7 7 7 11 16
Japan 125.1 121.6 261.5 154.3 34 167.4 82.2 26 5.3   7.4 7 7 11 13
Diabetes www.who.int/diabetes/facts/; Population www.cencus.gov/www/idb/summaries.html; WHO Mortality www.who.int/whosis/
database/mort/,  Japan/Singapore, 2006; Fiji, 1999; Philippines, 1998; Mongolia, 1994
are the data actually recent, and the vast majority are
estimates for the 1990s, rather than the 21st century. There
is major variation in the rates for cancer incidence and
mortality, and also to some extent in the ratio between the
two, reflecting differences in screening and early detection,
as well as capacity for treatment and cure.
For comparison, WHO estimates for the burden of
diabetes mellitus and percentage mortality from
circulatory diseases, divided into cerebrovascular and
cardiovascular, are also included in Table 6. Again there
is considerable variation, but the picture is of increase in
diabetes across the Asian Pacific.
A necessarily incomplete summary of elements of
cancer control programs in place is similarly provided in
Table 7, focusing on cancer registration, screening and
tobacco policy. Cancer control programs have been
described in the literature for India (Desai, 2002), Malaysia
(Lim (2002), Singapore (Hock et al., 2002), Indonesia
(Tjindarbumi and  Mangunkusumo, 2002), Thailand
(Vatanasapt et al., 2002); Viet Nam (Anh and Duc, 2002),
Taiwan (Chen et al., 2002), Korea (Anh, 2002; Yoo, 2008)
and Japan (Yamaguchi, 2002).
Of the total of 51 countries listed, only 19 have some
form of national center for cancer treatment, with research
capacity only in a minority of these. Regarding cancer
registration, only 20% of countries in Asia have
population-based registries, and only 4 (8%) covering their
entire populations. While  hospital-based registration is
being conducted in nearly all of the countries, we can
conclude that the present registry coverage is minimal in
19 (36%) of the total of 51 countries here included in Asia
and the Pacific  (17% have only rudimentary registration
Asian Pacific Journal of Cancer Prevention, Vol 11, 20107
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Table 7.  Cancer Control Programs in Asian Countries
Region/Country        Natl Cancer        Cancer Registration Cancer Screening             Tobacco STEPS
 Institution  National Population Hospital     Cervical  Mammary Other            M  F        ??
NW Turkey No* No 2 ? ? ? ? 04/04
Armenia No No ? ? ? ? ?  ? /04
Georgia Yes No ? ? ? ? ? 04/06
Azerbaijan No No ? ? ? ? ?  ? /05? ?
Iran Yes No 3 ? ? ? ? 03/05 Y
Turkmenistan No No ? ? ? ? ? ? ? ?
Uzbekistan No No ? ? ? ? ? ? ?
Kazakhstan Yes No ? ? Pap Mam ? 04/04
Kyrgyzstan Yes No 1? ? ? ? ? 04/06
Tadjikistan No No ? ? ? ? ? ? ?
Afghanistan No No ? ? ? ? ? 04/? ? ?
SW Syria No No ? ? ? ? ? 03/04 Y
Lebanon No No 1? ? ? ? ? 04/05 ?
Israel No Yes ? ? ? ? ? 03/05 ?
Jordan No Yes 1 ? ? ? ? 04/04 Y
Egypt Yes No 1 ? ? ? ? 03/05 Y
Saudi Arabia Yes No ? ? ? ? ? 04/05 Y
Yemen Yes No 1 ? ? ? ? 03/07 ?
Oman No Yes 1 ? ? ? ?  ? /05 Y
UAE No No ? ? ? ? ? 04/05 ?
Qatar No No ? 1 ? ? ? 03/04 ?
Bahrain No No ? ? ? ? ?  ? /07
Kuwait No No ? ? ? ? ? 03/06 Y
Iraq No No ? ? ? ? ? 04/08 Y
South Pakistan No No ? ? ? ? ? 04/04 Y
India Yes** No ? ? ? ? ? 03/04? Y
Sri Lanka Yes No ? ? ? ? ? 03/03 Y
Bangladesh Yes No ? ? ? ? ? 03/04 Y
Nepal Yes No ? 7 ? ? ? 03/06 Y
Bhutan No* No ? ? ? ? ? 03/04 Y
SE Myanmar No No ? ? ? ? ? 03/04 Y
Thailand Yes No ? ? Pap P/O ? 03/04 ?
Laos No No ? ? ? ? ? 04/06 ?
Cambodia No No ? ? ? ? ? 04/05 ?
Viet Nam Yes No ? ? ? ? ? 03/04 Y
Malaysia No No ? ? ? ? ? 03/05 Y
Singapore Yes No ? ? ? ? ? 03/04 ?
Brunei No* No ? ? ? ? ? 04/04
Indonesia Yes No ? ? ? ? ? ? ? Y
Philippines No No ? ? ? ? ? 03/05 ?
Pacific Papua NG No* No ? ? ? ? ? 04/06 ?
Solomons No No ? ? ? ? ? 04/04 ?
Vanuatu No No ? ? ? ? ? 04/05 ?
Fiji No No ? ? ? ? ? 03/03 Y
Guam Yes No ? ? ? ? ? ? ? ?
Samoa No No ? ? ? ? ? 03/05 Y
NE Mongolia Yes No ? ? ? ? ? 03/04 Y
China Yes No ? ? ? ? ? 03/05 ?
N Korea No No ? ? ? ? ? 03/05 Y
S Korea Yes No ? ? Pap Mam  Co/St/Li 03/05 ?
Japan Yes No 35 350 Pap Mam  Co/St/Lu 04/04 ?
Pap; Papanicalaou smear; Mam, mammography; Co, colorectal; St, stomach; Li, liver; Lu, lung *Reportedly in the
process of establishment
and over 65% have no CIV involvement).  As stressed by
Yang et al (2005), there are also great difficulties in
guaranteeing comparability even within individual
countries, like China. There are a number of regional
organizations which have been established to co-ordinate
and assist with promoting uniform data standards and
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Table 8. Cervical and Breast Cancer Opportunistic
Screening Rates for Selected Countries (from WHO*)
Country            Cervical               Breast
Urban   Rural    Total   Urban   Rural    Total
Israel 33.6 46.9 34.7 56.8 54.5 56.6
UAE 19.4 5.0 16.9 21.3 10.4 19.1
Georgia 15.4 6.1 11.2 3.5 1.3 2.5
Kazakhstan 77.1 69.4 73.4 40.7 33.3 37.6
Pakistan 3.4 1.0 1.9 0.3 0.1 0.8
India 4.9 2.3 2.6 6.5 1.2 1.8
Sri Lanka 1.7 1.2 1.3 1.9 1.1 1.3
Bangladesh 1.0 0.2 0.4 1.6 0.4 0.6
Nepal 4.7 2.0 2.4 6.3 1.5 2.0
Myanmar 4.7 2.0 2.4 6.3 1.5 2.0
Malaysia 23.6 21.9 23.0 13.7 6.9 11.1
Laos 5.3 1.4 2.2 4.1 0.5 1.3
Viet Nam 4.5 5.0 4.9 4.2 1.5 2.2
Philippines 9.3 5.0 7.7 5.4 3.4 4.6
China 21.5 14.8 16.8 16.4 20.6 19.2
training courses for cancer registration. In Asia we have
the Japanese Association of Cancer Registries (http://
home.att.ne.jp/grape/jacr/), the Chinese National Center
for Cancer Registries listed as Regional Cancer Registry
Organizations in the IARC website, as well as other
country-wide bodies.
The second arm of cancer control, along with health
promotion in general, is increased awareness for early
detection, and where feasible and of proven benefit,
population-based screening for preneoplastic or
premalignant lesions.  While such screening is solely
opportunistic in most of the countries of the region,
Singapore, Korea and Japan are exceptional in having
population-based screening programs for a number of
cases (see Table 7). Thailand has also started a population-
based program for cervical cancer and many countries
have conducted assessment projects. However, even where
they are in place, compliance may be poor.
WHO data for opportunistic screening rates for
cervical and breast cancer are also available for a selected
number of countries in Asia, as listed in Table 8. Of the
total of 15, for the cervix only 6 have rates above single
digits, this falling to 4 for rural populations. For the
mammary gland, the respective figures are 5 and 4.
A third pillar of cancer control programs is the strategy
for tobacco control. While all countries but Indonesia,
Turkmenistan, Uzbekistan and Tadjikistan have signed the
WHO Framework Convention on Tobacco control, there
are very few that have actually introduced most of the
included measures. Even basic data on smoking
prevalence are not up to date (see Table 7). STEPS surveys
have been carried out of non-communicable disease risk
factors in over half of the countries.
The present supplement was conceived with the idea
of bringing together interested parties within Asia in line
with recent moves to form an Asian Cancer Registry
Network (Moore et al., 2008). Taking advantage of the
facilities which are already available in the form of cancer
registries (see Figure 2), it is very feasible to build the
capacity to generate research data with practical
applications to assist governments in decisions as to
implementation of cancer control programs.
Figure 3. Concept of a Local Registration Center as a
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As argued by Coleman et al (2003), surveys of public
opinion, initiation of public debate, and legislation to
protect both citizens’ rights and medical research that is
demonstrably in the public interest, are high priorities. It
is natural that the registry could play a role in conducting
such surveys.  A start has in fact been made in Khon Kaen
registry in Thailand (Wiangnon et al., 2007). An Asian
Network, together with international players, could
provide coordination and leadership in the areas of T/F
(training/seed-financing) and how to reach out to the media
and interact with patient groups (see Figure 3). Assistance
could be given in research methodology and most
important, the publication or research findings.
To provide ammunition in support of more funding
for cancer registries and any Asian Network, research
needs to be conducted to actually explain differences
observed in incidence rates between and within countries
in a convincing way so that they offer practical application.
The question of financial support clearly will depend on
the ability to generate better understanding, and this should
be a stimulus to specific collaborative research, as argued
in the present volume (Moore and Sobue, 2010). More
stress might be given to cancer registries providing
survival data (Tanaka et al., 2010), perhaps in active
collaboration with cancer treatment centres (Evans et al.,
2002). Research into clinical epidemiology is a very high
priority and such activity by cancer registries might
stimulate more involvement and support from
pharmaceutical and information industries  (Kawahara,
2007a; 2007b). International collaboration should
facilitate making contacts with international industries
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Figure 4. Interacting Parties in Determination of
Health Benefit and Costs (after Kawahara, 2007b)
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with the aim of progressing towards this aim.
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